Skip to main content
TipRanks
Go Ultimate75% OFF

Mitsui Chemicals (MITUY) AI Stock Analysis

3 Followers
MITUY

Mitsui Chemicals

(Other OTC:MITUY)

Select Model
Rating:56Neutral
Price Target:$10.00â–²(0.91% Upside)
Action:reiterated
Date:11/14/26

The score reflects a middling but improving fundamental picture offset by poor price momentum, partly cushioned by an inexpensive valuation. Earnings, margins and return on equity are recovering strongly off a weak base and operating cash generation is dependable, but net margins remain thin and volatile, debt now slightly exceeds equity, and free cash flow has contracted as capital spending consumes most operating cash. Technically the stock is in a downtrend, trading below all key moving averages with negative MACD momentum. A low 7.8x P/E and 4.1% dividend yield provide valuation support and income, making this a stabilizing but not compelling overall profile pending confirmation that margin gains and deleveraging can be sustained through the chemical cycle.

Positive Factors
Diversified end-market portfolioMitsui Chemicals serves multiple industrial and healthcare applications through a broad mix of chemical products and materials. This diversification can reduce dependence on any single end market, support customer reach, and provide a durable platform for recovery across differing demand cycles.
Negative Factors
Rising leverageDebt has risen to roughly the level of equity, reducing financial flexibility compared with the prior annual period. Greater leverage can constrain investment and capital allocation choices, while making the company more exposed to earnings pressure if chemical industry conditions weaken.

Mitsui Chemicals (MITUY) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%MITUY-16.37%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$3.64B
Dividend Yield
4.68%
Average Volume (3M)
498
Price to Earnings (P/E)
6.7
Beta (1Y)
0.88
Revenue Growth
0.35%
EPS Growth
377.13%
Country
US
Employees
16,967
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals

Mitsui Chemicals Business Overview & Revenue Model

Company Description

Mitsui Chemicals, Inc. is a diversified chemical enterprise operating across key sectors including mobility, healthcare, food and packaging, and basic materials. Within its Mobility division, it develops and supplies elastomers, various performance c...

How the Company Makes Money

Mitsui Chemicals makes money primarily by manufacturing and selling chemical products and materials to business customers (B2B) in Japan and internationally. Its revenue model is product-sales driven, with earnings generated from (1) higher-volume co...

Mitsui Chemicals Earnings Call Summary

Earnings Call Date:Feb 04, 2025(Q3-2024)|% Change Since:-7.31%|Next Earnings Date:Feb 09, 2027
Earnings Call SentimentNegative

The earnings call highlighted growth in the Mobility Solutions segment and strong cash flow improvements, but these were overshadowed by significant declines in overall revenue, particularly in Basic & Green Materials, and continuing challenges in the semiconductor and smartphone markets. The forecast was also downgraded, indicating ongoing difficulties.

Positive Updates

Mobility Solutions Growth
Operating income before special items for the Mobility Solutions segment increased by JPY 2.1 billion year-over-year to JPY 41.0 billion, mainly due to growth in solar cell encapsulant materials and recovery in automotive applications.

Negative Updates

Overall Revenue Decline
Sales revenue for the April to December period was JPY 1.2745 trillion, a decrease of JPY 154.4 billion versus the same period last year. Operating income before special items decreased by JPY 37.9 billion.

Company Guidance

During the Mitsui Chemicals earnings call for the third quarter of fiscal year 2023, CFO Nakajima provided guidance indicating a challenging period due to sluggish demand in key markets and falling raw material prices, leading to a year-over-year decline in sales and profits. The company revised its full-year forecast for operating income before special items from JPY 112.0 billion to JPY 93.0 billion, and net income was adjusted downward to JPY 50.0 billion, partly due to restructuring losses. Despite these challenges, the annual dividend remains projected at JPY 140 per share. Significant declines in semiconductor and smartphone markets impacted the ICT solutions segment, while the Life & Healthcare segment struggled with inventory adjustments. Mobility Solutions showed resilience with a forecasted operating income increase to JPY 57.0 billion, driven by growth in solar cell materials and automotive recovery. Overall, Mitsui Chemicals anticipates a JPY 20.9 billion decrease in profit for the year, with free cash flows expected to be positive at JPY 24.0 billion.

Mitsui Chemicals Financial Statement Overview

Summary

Mitsui Chemicals is in the early stages of a cyclical earnings recovery. Revenue returned to growth (+6.5% TTM), gross margin expanded from ~20% to ~24%, operating margin nearly doubled to 7.6%, and net income more than doubled to about ¥86 billion, lifting return on equity to ~9.7%. Operating cash flow of ~¥176 billion is roughly twice net income, indicating good cash quality. However, net margin remains thin at ~4.7% and historically volatile, leverage has risen with debt-to-equity above 1.0x (from 0.86x) and equity funding only ~36% of assets, and free cash flow fell ~24% to ~¥41 billion as capital spending absorbs most operating cash. The profile is financially stable rather than strong.

Income Statement

58Neutral

Balance Sheet

52Neutral

Cash Flow

55Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2026Mar 2025Mar 2024Mar 2023
Income Statement
Total Revenue1.74T1.81T1.77T1.75T1.88T1.61T
Gross Profit378.77B388.29B403.46B370.80B381.49B378.74B
EBITDA151.44B186.12B202.22B183.24B182.81B216.99B
Net Income17.98B32.24B36.45B50.00B82.94B109.99B
Balance Sheet
Total Assets2.10T2.15T2.16T2.22T2.07T1.93T
Cash, Cash Equivalents and Short-Term Investments198.75B209.23B183.91B249.51B262.72B224.65B
Total Debt696.42B737.98B743.40B756.76B738.25B666.09B
Total Liabilities1.12T1.18T1.17T1.23T1.18T1.13T
Stockholders Equity854.37B848.28B868.48B862.85B786.83B712.65B
Cash Flow
Free Cash Flow84.49B62.09B89.86B7.35B-36.62B-23.63B
Operating Cash Flow212.32B200.50B225.83B161.34B101.24B92.58B
Investing Cash Flow-153.26B-165.01B-145.41B-123.94B-106.34B-205.23B
Financing Cash Flow-33.74B-74.44B-78.00B-26.02B2.54B89.22B

Mitsui Chemicals Technical Analysis

Technical Analysis SentimentNegative
Last Price9.91

Price Trends

50DMA12.76Negative
100DMA13.14Negative
200DMA13.11Negative

Market Momentum

MACD-0.75Positive
RSI26.77Positive
STOCH23.04Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MITUY, the sentiment is Negative. The current price of 9.91 is below the 20-day moving average (MA) of 11.69, below the 50-day MA of 12.76, and below the 200-day MA of 13.11, indicating a bearish trend. The MACD of -0.75 indicates Positive momentum. The RSI at 26.77 is Positive, neither overbought nor oversold. The STOCH value of 23.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MITUY.

Mitsui Chemicals Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

MITUY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
CECE61Neutral$4.94B18.916.35%0.27%1.43%―
MITUYMITUY56Neutral$3.68B6.749.74%4.68%0.35%377.13%
DDDD55Neutral$19.27B64.642.18%1.65%-43.45%―
DOWDOW52Neutral$21.01B-23.04-4.50%4.82%4.16%20.86%
HUNHUN44Neutral$1.47B-8.76-6.12%4.19%6.49%47.81%
BAKBAK42Neutral$386.35M-0.3845.33%―8.56%-31.27%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%MITUYCEBAKHUNDDDOWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MITUY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MITUYMitsui Chemicals (OTC)9.91-1.95-16.43%
CECelanese45.016.3516.43%
BAKBraskem Sa0.74-2.25-75.32%
HUNHuntsman8.36-0.21-2.42%
DDDuPont de Nemours, Inc.145.4332.0228.23%
DOWDow Inc.29.037.5635.21%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026